Literature DB >> 10979749

Hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti-hepatitis B virus antibody levels but negative for HBsAg.

W N Chen, C J Oon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10979749      PMCID： PMC87037          DOI： 10.1128/JCM.38.7.2793-2794.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

1.  Horizontal transmission of a hepatitis B virus surface antigen mutant.

Authors:  W N Chen; C J Oon; S Koh
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.

Authors:  J M Jongerius; M Wester; H T Cuypers; W R van Oostendorp; P N Lelie; C L van der Poel; E F van Leeuwen
Journal:  Transfusion       Date:  1998-01       Impact factor: 3.157

3.  Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff.

Authors:  M Cabrerizo; J Bartolomé; P De Sequera; C Caramelo; V Carreño
Journal:  J Am Soc Nephrol       Date:  1997-09       Impact factor: 10.121

4.  Molecular epidemiology of hepatitis B virus vaccine variants in Singapore.

Authors:  C J Oon; G K Lim; Z Ye; K T Goh; K L Tan; S L Yo; E Hopes; T J Harrison; A J Zuckerman
Journal:  Vaccine       Date:  1995       Impact factor: 3.641

5.  The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.

Authors:  L Weiss; A S Kekulè; U Jakubowski; E Bürgelt; P H Hofschneider
Journal:  Virology       Date:  1996-02-01       Impact factor: 3.616

Review 6.  Human hepatitis B virus mutants: significance of molecular changes.

Authors:  W N Chen; C J Oon
Journal:  FEBS Lett       Date:  1999-06-25       Impact factor: 4.124

7.  Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir.

Authors:  C J Oon; W N Chen; N Lim; S Koh; G K Lim; A L Leong; G S Tan
Journal:  Antiviral Res       Date:  1999-04       Impact factor: 5.970

Review 8.  Hepatitis B surface antigen variation and protective immunity.

Authors:  C R Howard; L M Allison
Journal:  Intervirology       Date:  1995       Impact factor: 1.763

9.  Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction.

Authors:  L J Scully; H Sung; R Pennie; P Gill
Journal:  J Med Virol       Date:  1994-11       Impact factor: 2.327
  9 in total
  14 in total

1.  A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis.

Authors:  Xu Yang; Xiao-Peng Tang; Jian-Hua Lei; Hong-Yu Luo; Yong-Hong Zhang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Antigenic and immunogenic changes due to mutation of s gene of HBV.

Authors:  Jun-Hui Ge; Hui-Min Liu; Jing Sun; Le-Zhi Zhang; Jin He; Yu-Li Li; Hong Liu; Yi Xu; Hong-Yu Yu; Yi-Ping Hu
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

3.  Vaccination and the dynamics of immune evasion.

Authors:  Olivier Restif; Bryan T Grenfell
Journal:  J R Soc Interface       Date:  2007-02-22       Impact factor: 4.118

4.  Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance.

Authors:  C Sarrecchia; V Svicher; A Volpi; R Salpini; L Ceccarelli; P Sordillo; A Bertoli; C F Perno; M Andreoni
Journal:  Infection       Date:  2011-06-15       Impact factor: 3.553

5.  Evaluation of the highly sensitive chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B virus screening.

Authors:  Matsuo Deguchi; Masanori Kagita; Nori Yoshioka; Hiroko Tsukamoto; Miyuki Takao; Kazuko Tahara; Ikuhiro Maeda; Yoh Hidaka; Satoshi Yamauchi; Atsushi Kaneko; Hideo Miyakoshi; Mitsuo Isomura
Journal:  J Clin Lab Anal       Date:  2017-10-06       Impact factor: 2.352

6.  Incidence of HBV variants with a mutation at nt551 among hepatitis B patients in Nanjing and its neighbourhood.

Authors:  Chun-Ling Ma; De-Xing Fang; Kun Yao; Fa-Qing Li; Hui-Ying Jin; Su-Qin Li; Wei-Guo Tan
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

7.  Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination.

Authors:  Qing-Qing Yao; Xiao-Lian Dong; Xue-Cai Wang; Sheng-Xiang Ge; An-Qun Hu; Hai-Yan Liu; Yueping Alex Wang; Quan Yuan; Ying-Jie Zheng
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

Review 8.  Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B.

Authors:  Lung-Yi Mak; Wai-Kay Seto; James Fung; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2019-11-19       Impact factor: 6.047

9.  Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.

Authors:  Daniela Bottero; María Emilia Gaillard; Matías Fingermann; Gabriela Weltman; Julieta Fernández; Federico Sisti; Augusto Graieb; Roy Roberts; Osvaldo Rico; Gustavo Ríos; Mabel Regueira; Norma Binsztein; Daniela Hozbor
Journal:  Clin Vaccine Immunol       Date:  2007-08-15

10.  A mutation specific polymerase chain reaction for detecting hepatitis B virus genome mutations at nt551.

Authors:  Chun-Ling Ma; De-Xing Fang; Hua-Biao Chen; Fa-Qing Li; Hui-Ying Jin; Su-Qin Li; Wei-Guo Tan
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.